<?xml version="1.0" encoding="UTF-8"?>
<p>Of the 7 patients who were assigned to receive SYT, only 2 continued for &gt;30 days. Reasons for discontinuation included persistent leukopenia, herpes zoster, and relapse. We were aware of at least 2 other patients enrolled in the trial who did not receive SYT but sought CHM treatment elsewhere.</p>
